导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -14.30% | 892/1050 |
| 近一周 | -3.33% | 863/1104 |
| 近一月 | -5.49% | 656/1102 |
| 近一季 | -6.24% | 477/1092 |
| 近半年 | -17.61% | 945/1070 |
| 近一年 | -11.28% | 760/1018 |
| 近两年 | 42.62% | 556/926 |
| 近三年 | 31.56% | 382/834 |
| 成立以来 | 84.74% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.67% 608/1070 |
-15.13% 1016/1101 |
- - |
- - |
| 2025 | 37.87% 353/1065 |
7.04% 281/1014 |
4.52% 325/1038 |
19.89% 612/1050 |
2.78% 257/1065 |
| 2024 | 19.74% 94/1011 |
-0.35% 332/960 |
8.91% 24/983 |
14.01% 302/991 |
-3.23% 552/1011 |
| 2023 | -21.57% 703/952 |
-3.36% 758/880 |
-7.54% 670/895 |
-8.14% 507/915 |
-4.44% 446/952 |
| 2022 | -20.56% 346/867 |
-21.84% 630/773 |
16.14% 92/806 |
-26.49% 802/845 |
19.04% 24/867 |
| 2021 | -14.49% 511/740 |
-2.96% 267/580 |
8.15% 405/659 |
-14.63% 601/704 |
-4.56% 584/740 |
| 2020 | 47.97% 245/554 |
-7.92% 354/419 |
20.70% 274/466 |
7.04% 319/517 |
24.39% 77/554 |
| 2019 | 45.74% 179/410 |
27.39% 523/1146 |
-1.01% 442/1228 |
2.39% 270/390 |
12.88% 95/410 |
| 2018 | -27.46% 184/349 |
- - |
-8.66% 403/990 |
-6.11% 514/1000 |
-11.94% 570/1080 |
| 2017 | 30.75% 37/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信沪港深A VS. 东吴新产业精选股票A(580008) |